Tom Brady recently announced that he cloned his dog. Learn more about the wild world of pet cloning and how much it costs.

NANTES, France, November 7, 2025 – 6:00pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), a clinical-stage biotechnology company developing immunotherapies for cancer and autoimmune ...

Global equity funds saw a surge in inflows in the week through November 5 as investors, optimistic about rising artificial ...

In a move to cement its position as India’s startup capital, Karnataka has unveiled a Rs 518 crore plan to support 25,000 new ...

Q3 2025 Earnings Call Transcript November 6, 2025 Novavax, Inc. misses on earnings expectations. Reported EPS is $-1.24654 ...

The net result as of September 30, 2025 improved by $1.1M compared to September 2024, following termination of a Convertible Bonds financing facility with Nice&Green CNS(Vafidemstat) Received feedback ...

These five Dividend Kings offer investors a solid source of passive income, and are among the safest picks in the group.

In interviews with The Daily Cardinal, tech leaders Jim Thompson, Mike Trigg and Allen Dines reflect on how AI has shaped ...

A biomedical researcher combining advanced mouse models with human-based and computational approaches explains why we can’t ...

Market opportunities lie in modernizing software development and validation approaches, emphasizing agility and continuous validation to meet changing needs, while ensuring compliance with FDA ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

Today, Gubra releases its results for the third quarter of 2025. In September, Gubra welcomed Markus Rohrwild as our new CEO. The third quarter has been characterized by expansion of our R&D ...